on 23 Jun 2020
Last Applicant/ Owned by
Lerso Parkallé 44, 5.Floor
Copenhagen
DK
2100
Serial Number
88511801 filed on 12th Jul 2019
Registration Number
6083472 registered on 23rd Jun 2020
Correspondent Address
Mark H. Tidman
BAKER & HOSTETLER LLP
1050 Connecticut Avenue, NW
Washington Square, Suite 1100
Washington, DC, , 20036-5403
Filing Basis
No Filing Basis
Disclaimer
NO DATA
Pharmaceutical preparations, namely, antibacterial treatments, microbiome modulating treatments, anti-infective treatments and prophylaxis; medical preparations, namely, antibacterial treatments, microbiome modulating treatments, anti-infective treatments and prophylaxis, and medical diagnostics; veterinary preparations for antibacterial treatments, microbiome modulating treatments, anti-infectiveRead More
Pharmaceutical preparations, namely, antibacterial treatments, microbiome modulating treatments, anti-infective treatments and prophylaxis; medical preparations, namely, antibacterial treatments, microbiome modulating treatments, anti-infective treatments and prophylaxis, and medical diagnostics; veterinary preparations for antibacterial treatments, microbiome modulating treatments, anti-infective treatments and prophylaxis, and medical diagnostics; sanitary preparations for medical purposes; dietetic food and beverages adapted for medical or veterinary use; dietary supplements for human beings and animals; dietary supplements; antibiotic preparations; pharmaceutical preparations, namely, antiviral preparations; probiotic supplements; probiotic supplements for medical use; probiotic formulations for veterinary use, namely, probiotic nutritional supplements; probiotic formulations for medical use, namely, probiotic nutritional supplements; animal feed additives for use in animals feed to assist in digestion, growth or wellbeing; microbiome modulators for medical purposes, namely, targeted antimicrobial treatments for disease prevention or alteration; guided nuclease-based biocides; CRISPR-based biocides; pharmaceutical preparations for the treatment or prevention of disorders or diseases caused by bacteria
Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; scientific and technological services, namely, scientific research, analysis and testing in the field of diseases and conditions associated with bacteria; industrial analysis and industrial research services; design and development of computer hardware and software; genetic microbiology and microbiome research; genetic engineering and services; design and development of hardware and software; clinical research; pharmaceutical research and development; development of pharmaceutical preparations and medicines; research and development services in the field of antibiotics; research and development of guided nuclease-based biocides; research and development of CRISPR-based biocides; research and development of CRISPR technology for the treatment of microbial diseases; clinical trials; clinical research; conducting clinical trials for pharmaceutical products; bacteriological research; viral research; biological research; scientific and medical screening and assaying; chemical analysis; chemical research
Medical services; diagnostic and prognostic medical services; veterinary services; medical analysis services relating to the treatment of persons in the nature of diagnostic and treatment counseling regarding the treatment of medical conditions and disease; advice; medical and health services relating to DNA, genetics and genetic pathogen testing, namely, genetic testing for medical purposes; genetic counseling
No 88511801
No Service Mark
No 86291.020199
No
No
No
No
No
No
No
No
| Status Date | Action Taken |
|---|---|
| 23rd Jun 2020 | REGISTERED-PRINCIPAL REGISTER |
| 07th Apr 2020 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 07th Apr 2020 | PUBLISHED FOR OPPOSITION |
| 18th Mar 2020 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| 03rd Mar 2020 | LAW OFFICE PUBLICATION REVIEW COMPLETED |
| 02th Mar 2020 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| 01st Feb 2020 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| 01st Feb 2020 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| 31st Jan 2020 | ASSIGNED TO LIE |
| 28th Jan 2020 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
